Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The article concludes that the wool follicle is a valuable model for studying tissue interactions and has potential for genetic improvements in wool production.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

Stem cell treatments may improve burn wound healing.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Nitroglycerin ointment is now used to treat several skin conditions with fewer side effects.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

New hair follicles could be created to treat hair loss.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The new microwell device helps grow more hair stem cells that can regenerate hair.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Microneedling can effectively treat hair loss and works well with other treatments, but more research is needed.

The method can test hair growth products using a lab-made hair-like structure that responds to known treatments.

MicroRNAs play a key role in controlling hair growth and quality in sheep and goats.

Polydopamine is a safe, effective, and permanent hair dye that turns gray hair black in one hour.

Current hair regeneration methods show promise but face challenges in maintaining cell effectiveness and creating the right environment for hair growth.

Skin-on-a-chip devices better mimic human skin for research.

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

iPSCs could help develop treatments for hair loss.